Tech Company Financing Transactions

Cellerant Therapeutics Funding Round

Cellerant Therapeutics closed a $2.3 million funding round on 6/30/2010. Backers included Allen & Company, Camelot Ventures and private investors.

Transaction Overview

Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$2,288,000
Round
Undisclosed
Investors

Allen & Company (Steven Greenberg)

Camelot Ventures (Richard Chyette)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1561 Industrial Rd.
San Carlos, CA 94070
USA
Email Address
Overview
Cellerant Therapeutics is a biotechnology company offering products for the regulation of the hematopoietic system.
Profile
Cellerant Therapeutics LinkedIn Company Profile
Social Media
Cellerant Therapeutics Company Twitter Account
Company News
Cellerant Therapeutics News
Facebook
Cellerant Therapeutics on Facebook
YouTube
Cellerant Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ram Mandalam
  Ram Mandalam LinkedIn Profile  Ram Mandalam Twitter Account  Ram Mandalam News  Ram Mandalam on Facebook
Chief Financial Officer
Rodney Young
  Rodney Young LinkedIn Profile  Rodney Young Twitter Account  Rodney Young News  Rodney Young on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2010: Evoke Pharma venture capital transaction
Next: 6/30/2010: TeachTown venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to record funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary